Location: Seattle, WA, USA.
Based on news reporting.
Astellas Gene Therapies, Inc. has announced the closure of its Seattle office, resulting in the layoff of approximately 36 employees. This decision comes as part of a strategic shift within the company, which is focusing on its core operations. The layoffs are expected to take effect shortly, impacting the local workforce significantly. The company has not specified the exact reasons for the office closure but indicated a need to streamline operations. This move reflects broader trends in the pharmaceutical industry as companies reassess their operational footprints.
Astellas Gene Therapies, Inc. cut 36 jobs as of October 1, 2023.
LayoffTalk has tracked 4 layoff events at Astellas Gene Therapies, Inc. since October 2023, affecting a combined 107 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.